-
1
-
-
33845270990
-
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
-
Toledo F., and Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6 (2006) 909-923
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 909-923
-
-
Toledo, F.1
Wahl, G.M.2
-
2
-
-
0036674617
-
Live or let die: the cell's response to p53
-
Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2 (2002) 594-604
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 594-604
-
-
Vousden, K.H.1
Lu, X.2
-
3
-
-
19744368302
-
Cancer of the ovary
-
Cannistra S.A. Cancer of the ovary. N Engl J Med 351 (2004) 2519-2529
-
(2004)
N Engl J Med
, vol.351
, pp. 2519-2529
-
-
Cannistra, S.A.1
-
4
-
-
0031818322
-
Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to taxol by inducing G2 arrest and apoptosis
-
Vikhanskaya F., Vignati S., Beccaglia P., Ottoboni C., Russo P., D'Incalci M., et al. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to taxol by inducing G2 arrest and apoptosis. Exp Cell Res 241 (1998) 96-101
-
(1998)
Exp Cell Res
, vol.241
, pp. 96-101
-
-
Vikhanskaya, F.1
Vignati, S.2
Beccaglia, P.3
Ottoboni, C.4
Russo, P.5
D'Incalci, M.6
-
5
-
-
0031009631
-
p53 in drug resistance in ovarian cancer
-
Lavarino C., Delia D., Di Palma S., Zunino F., and Pilotti S. p53 in drug resistance in ovarian cancer. Lancet 349 (1997) 1556
-
(1997)
Lancet
, vol.349
, pp. 1556
-
-
Lavarino, C.1
Delia, D.2
Di Palma, S.3
Zunino, F.4
Pilotti, S.5
-
6
-
-
8944263468
-
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems
-
Perego P., Giarola M., Righetti S.C., et al. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 56 (1996) 556-562
-
(1996)
Cancer Res
, vol.56
, pp. 556-562
-
-
Perego, P.1
Giarola, M.2
Righetti, S.C.3
-
7
-
-
33646798450
-
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress
-
Murray-Zmijewski F., Lane D.P., and Bourdon J.C. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13 (2006) 962-972
-
(2006)
Cell Death Differ
, vol.13
, pp. 962-972
-
-
Murray-Zmijewski, F.1
Lane, D.P.2
Bourdon, J.C.3
-
8
-
-
0030812331
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
-
Kaghad M., Bonnet H., Yang A., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90 (1997) 809-819
-
(1997)
Cell
, vol.90
, pp. 809-819
-
-
Kaghad, M.1
Bonnet, H.2
Yang, A.3
-
9
-
-
0032161624
-
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
-
Yang A., Kaghad M., Wang Y., et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
-
(1998)
Mol Cell
, vol.2
, pp. 305-316
-
-
Yang, A.1
Kaghad, M.2
Wang, Y.3
-
10
-
-
0345059168
-
Functional regulation of p73 and p63: development and cancer
-
Melino G., Lu X., Gasco M., Crook T., and Knight R.A. Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28 (2003) 663-670
-
(2003)
Trends Biochem Sci
, vol.28
, pp. 663-670
-
-
Melino, G.1
Lu, X.2
Gasco, M.3
Crook, T.4
Knight, R.A.5
-
11
-
-
0035966345
-
p53, p63 and p73-solos, alliances and feuds among family members
-
Moll U.M., Erster S., and Zaika A. p53, p63 and p73-solos, alliances and feuds among family members. Biochim Biophys Acta 1552 (2001) 47-59
-
(2001)
Biochim Biophys Acta
, vol.1552
, pp. 47-59
-
-
Moll, U.M.1
Erster, S.2
Zaika, A.3
-
12
-
-
3543110350
-
p63 and p73: roles in development and tumour formation
-
Moll U.M., and Slade N. p63 and p73: roles in development and tumour formation. Mol Cancer Res 2 (2004) 371-386
-
(2004)
Mol Cancer Res
, vol.2
, pp. 371-386
-
-
Moll, U.M.1
Slade, N.2
-
13
-
-
1242318518
-
p53 protein variants: structural and functional similarities with p63 and p73 isoforms
-
Courtois S., de Fromentel C.C., and Hainaut P. p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene 23 (2004) 631-638
-
(2004)
Oncogene
, vol.23
, pp. 631-638
-
-
Courtois, S.1
de Fromentel, C.C.2
Hainaut, P.3
-
14
-
-
24344448786
-
p53 isoforms can regulate p53 transcriptional activity
-
Bourdon J.C., Fernandes K., Murray-Zmijewski F., et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19 (2005) 2122-2137
-
(2005)
Genes Dev
, vol.19
, pp. 2122-2137
-
-
Bourdon, J.C.1
Fernandes, K.2
Murray-Zmijewski, F.3
-
15
-
-
22144463164
-
A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint
-
Rohaly G., Chemnitz J., Dehde S., et al. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122 (2005) 21-32
-
(2005)
Cell
, vol.122
, pp. 21-32
-
-
Rohaly, G.1
Chemnitz, J.2
Dehde, S.3
-
17
-
-
3042813412
-
p63: molecular complexity in development and cancer
-
Westfall M.D., and Pietenpol J.A. p63: molecular complexity in development and cancer. Carcinogenesis 25 (2004) 857-864
-
(2004)
Carcinogenesis
, vol.25
, pp. 857-864
-
-
Westfall, M.D.1
Pietenpol, J.A.2
-
18
-
-
11144357549
-
Transdominant {Delta}TAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo
-
Concin N., Becker K., Slade N., et al. Transdominant {Delta}TAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res 64 (2004) 2449-2460
-
(2004)
Cancer Res
, vol.64
, pp. 2449-2460
-
-
Concin, N.1
Becker, K.2
Slade, N.3
-
19
-
-
0037439444
-
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors
-
Kmet L.M., Cook L.S., and Magliocco A.M. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 97 (2003) 389-404
-
(2003)
Cancer
, vol.97
, pp. 389-404
-
-
Kmet, L.M.1
Cook, L.S.2
Magliocco, A.M.3
-
20
-
-
0037219841
-
TP53 and ovarian cancer
-
Schuijer M., and Berns E.M. TP53 and ovarian cancer. Hum Mutat 21 (2003) 285-291
-
(2003)
Hum Mutat
, vol.21
, pp. 285-291
-
-
Schuijer, M.1
Berns, E.M.2
-
21
-
-
33846568870
-
Expression of p53 isoforms in squamous cell carcinoma of the head and neck
-
Boldrup L., Bourdon J.C., Coates P.J., Sjostrom B., and Nylander K. Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur J Cancer 43 (2007) 617-623
-
(2007)
Eur J Cancer
, vol.43
, pp. 617-623
-
-
Boldrup, L.1
Bourdon, J.C.2
Coates, P.J.3
Sjostrom, B.4
Nylander, K.5
-
22
-
-
0037130473
-
p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop
-
Kartasheva N.N., Contente A., Lenz-Stoppler C., Roth J., and Dobbelstein M. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene 21 (2002) 4715-4727
-
(2002)
Oncogene
, vol.21
, pp. 4715-4727
-
-
Kartasheva, N.N.1
Contente, A.2
Lenz-Stoppler, C.3
Roth, J.4
Dobbelstein, M.5
-
23
-
-
0346725958
-
DeltaNp73beta is active in transactivation and growth suppression
-
Liu G., Nozell S., Xiao H., and Chen X. DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol 24 (2004) 487-501
-
(2004)
Mol Cell Biol
, vol.24
, pp. 487-501
-
-
Liu, G.1
Nozell, S.2
Xiao, H.3
Chen, X.4
|